Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.285 USD | -4.18% | -11.51% | +49.02% |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
Apr. 01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.02% | 367M | |
+7.65% | 113B | |
+10.96% | 106B | |
+0.41% | 22.27B | |
-11.98% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.83% | 17.24B | |
+7.01% | 14.29B | |
+35.27% | 12.52B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Transcript : Solid Biosciences Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 09